Septerna, Inc.
SEPN
Jodie situation report
Septerna, Inc.'s move is being confirmed by its market group.
No new filing conclusion is available. 16 of 18 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 8 directly disclosed connections are confirming.
- At least 12 of 18 members remain active in the next snapshot.
- Capital-flow agreement rises above 55%.
- A filing-linked outsider such as ROIV begins moving with the group.
Invalidation: The live read weakens if participation falls to 6 of 18 members or fewer.
Who this business touches
The relationships behind SEPN
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
NVONovo Nordisk A/ScustomerMar 9, 2026 ▾
“Accordingly, the Company assessed this arrangement in accordance with ASC 606 and concluded that the contract counterparty, Novo, is a customer.”
NVONovo Nordisk A/SpartnerMar 9, 2026 ▾
“In July 2025, upon the effectiveness of our Novo Collaboration Agreement, we received a one-time, non-refundable upfront payment of $195.0 million (see “Novo Collaboration Agreement”).”
VERXVertex, Inc.partnerMar 9, 2026 ▾
“Collaboration and Research Service Agreements For the year ended December 31, 2025, the Company's revenue is comprised solely of arrangements with Novo and Vertex.”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 6 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
SEPN is currently a Participant in the organic co-movement group Biotech Rare Diseases. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.